39454290|t|Isoliquiritigenin alleviates cerebral ischemia-reperfusion injury by reducing oxidative stress and ameliorating mitochondrial dysfunction via activating the Nrf2 pathway.
39454290|a|Cerebral ischemia-reperfusion injury (CIRI) refers to a secondary brain injury that occurs when blood supply is restored to ischemic brain tissue and is one of the leading causes of adult disability and mortality. Multiple pathological mechanisms are involved in the progression of CIRI, including neuronal oxidative stress and mitochondrial dysfunction. Isoliquiritigenin (ISL) has been preliminarily reported to have potential neuroprotective effects on rats subjected to cerebral ischemic insult. However, the protective mechanisms of ISL have not been elucidated. This study aims to further investigate the effects of ISL-mediated neuroprotection and elucidate the underlying molecular mechanism. The findings indicate that ISL treatment significantly alleviated middle cerebral artery occlusion (MCAO)-induced cerebral infarction, neurological deficits, histopathological damage, and neuronal apoptosis in mice. In vitro, ISL effectively mitigated the reduction of cell viability, Na+-K+-ATPase, and MnSOD activities, as well as the degree of DNA damage induced by oxygen-glucose deprivation (OGD) injury in PC12 cells. Mechanistic studies revealed that administration of ISL evidently improved redox homeostasis and restored mitochondrial function via inhibiting oxidative stress injury and ameliorating mitochondrial biogenesis, mitochondrial fusion-fission balance, and mitophagy. Moreover, ISL facilitated the dissociation of Keap1/Nrf2, enhanced the nuclear transfer of Nrf2, and promoted the binding activity of Nrf2 with ARE. Finally, ISL obviously inhibited neuronal apoptosis by activating the Nrf2 pathway and ameliorating mitochondrial dysfunction in mice. Nevertheless, Nrf2 inhibitor brusatol reversed the mitochondrial protective properties and anti-apoptotic effects of ISL both in vivo and in vitro. Overall, our findings revealed that ISL exhibited a profound neuroprotective effect on mice following CIRI insult by reducing oxidative stress and ameliorating mitochondrial dysfunction, which was closely related to the activation of the Nrf2 pathway.
39454290	0	17	Isoliquiritigenin	Chemical	MESH:C040920
39454290	29	65	cerebral ischemia-reperfusion injury	Disease	MESH:D015427
39454290	112	137	mitochondrial dysfunction	Disease	MESH:D028361
39454290	157	161	Nrf2	Gene	83619
39454290	171	207	Cerebral ischemia-reperfusion injury	Disease	MESH:D015427
39454290	209	213	CIRI	Disease	MESH:D015427
39454290	237	249	brain injury	Disease	MESH:D001930
39454290	295	309	ischemic brain	Disease	MESH:D020520
39454290	453	457	CIRI	Disease	MESH:D015427
39454290	499	524	mitochondrial dysfunction	Disease	MESH:D028361
39454290	526	543	Isoliquiritigenin	Chemical	MESH:C040920
39454290	545	548	ISL	Chemical	MESH:C040920
39454290	627	631	rats	Species	10116
39454290	645	662	cerebral ischemic	Disease	MESH:D002547
39454290	709	712	ISL	Chemical	MESH:C040920
39454290	793	796	ISL	Chemical	MESH:C040920
39454290	899	902	ISL	Chemical	MESH:C040920
39454290	938	970	middle cerebral artery occlusion	Disease	MESH:D020244
39454290	972	976	MCAO	Disease	MESH:D020244
39454290	986	1005	cerebral infarction	Disease	MESH:D002544
39454290	1007	1028	neurological deficits	Disease	MESH:D009461
39454290	1030	1047	histopathological	Disease	
39454290	1060	1078	neuronal apoptosis	Disease	MESH:D065703
39454290	1082	1086	mice	Species	10090
39454290	1098	1101	ISL	Chemical	MESH:C040920
39454290	1176	1181	MnSOD	Gene	24787
39454290	1241	1255	oxygen-glucose	Chemical	-
39454290	1284	1288	PC12	CellLine	CVCL:0481
39454290	1348	1351	ISL	Chemical	MESH:C040920
39454290	1402	1415	mitochondrial	Disease	MESH:D028361
39454290	1481	1494	mitochondrial	Disease	MESH:D028361
39454290	1507	1520	mitochondrial	Disease	MESH:D028361
39454290	1570	1573	ISL	Chemical	MESH:C040920
39454290	1606	1611	Keap1	Gene	117519
39454290	1612	1616	Nrf2	Gene	83619
39454290	1651	1655	Nrf2	Gene	83619
39454290	1694	1698	Nrf2	Gene	83619
39454290	1718	1721	ISL	Chemical	MESH:C040920
39454290	1742	1760	neuronal apoptosis	Disease	MESH:D065703
39454290	1779	1783	Nrf2	Gene	83619
39454290	1809	1834	mitochondrial dysfunction	Disease	MESH:D028361
39454290	1838	1842	mice	Species	10090
39454290	1858	1862	Nrf2	Gene	83619
39454290	1873	1881	brusatol	Chemical	MESH:C020237
39454290	1895	1908	mitochondrial	Disease	MESH:D028361
39454290	1961	1964	ISL	Chemical	MESH:C040920
39454290	2028	2031	ISL	Chemical	MESH:C040920
39454290	2079	2083	mice	Species	10090
39454290	2094	2098	CIRI	Disease	MESH:D015427
39454290	2152	2177	mitochondrial dysfunction	Disease	MESH:D028361
39454290	2230	2234	Nrf2	Gene	83619
39454290	Positive_Correlation	MESH:C040920	24787
39454290	Association	MESH:D028361	83619
39454290	Bind	117519	83619
39454290	Negative_Correlation	MESH:C020237	83619
39454290	Negative_Correlation	MESH:C040920	MESH:D002544
39454290	Negative_Correlation	MESH:C020237	MESH:D028361
39454290	Association	MESH:D015427	83619
39454290	Association	MESH:C020237	MESH:C040920
39454290	Negative_Correlation	MESH:C040920	MESH:D020244
39454290	Negative_Correlation	MESH:C040920	MESH:D002547
39454290	Positive_Correlation	MESH:C040920	MESH:D028361
39454290	Negative_Correlation	MESH:C040920	MESH:D015427
39454290	Negative_Correlation	MESH:C040920	MESH:D065703
39454290	Negative_Correlation	MESH:C040920	MESH:D009461
39454290	Association	MESH:C040920	117519
39454290	Positive_Correlation	MESH:C040920	83619

